Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Verteporfin Beyond PDT: A Translational Strategy
2026-08-19
Verteporfin, also known as CL 318952, is more than a light-activated photosensitizer. Its distinct photodynamic and light-independent effects create a strategic platform for studying vascular selectivity, cell death, autophagy, and context-dependent drug response, including the influence of tumor viscosity and mechanobiology.
-
Podophyllotoxin: Reliable Cell Assay Workflows
2026-08-19
This practical guide uses five laboratory scenarios to show how Podophyllotoxin (SKU N1790) can support interpretable cell viability, proliferation, cell-cycle, and cytotoxicity experiments. It focuses on solvent compatibility, protocol optimization, autophagy interpretation, and evidence-based vendor selection.
-
Chronic Stress, Mitochondria, and MnTBAP in Rats
2026-08-18
A February 2025 study shows that chronic unpredictable mild stress produces depression-like behavior alongside mitochondrial dysfunction and neuroinflammation in the rat hippocampus and prefrontal cortex. The behavioral improvement observed after intracerebroventricular MnTBAP administration supports a mechanistic relationship between mitochondrial redox imbalance, inflammatory signaling, and stress-related phenotypes.
-
Gramine, CUL3–MTDH, and Ferroptosis in TNBC
2026-08-18
A 2026 study identifies gramine as a candidate suppressor of triple-negative breast cancer by linking CUL3 target engagement to MTDH stabilization and ferroptosis. Its combined chemical-screening, target-validation, rescue, and xenograft strategy provides a useful framework for distinguishing pathway association from mechanistic causality in TNBC research.
-
Levofloxacin: From DNA Gyrase to Tissue Assays
2026-08-17
Levofloxacin is a synthetic fluoroquinolone antibiotic with a distinctive DNA replication mechanism and measurable effects in bone and cartilage models. This guide connects bacterial target biology with endpoint-specific assay interpretation, using ceftolozane/tazobactam pharmacology as a framework for stronger experimental decisions.
-
Idoxuridine Workflows for Viral DNA Research
2026-08-17
Idoxuridine, also known as 5-iodo-2'-deoxyuridine, gives researchers a practical way to interrogate viral DNA synthesis and replication dynamics. This guide combines solvent handling, orthogonal antiviral readouts, assay controls, and troubleshooting strategies for reproducible herpes simplex virus research.
-
Merimepodib (VX-497): Targeting IMPDH for Translation
2026-08-16
Merimepodib (VX-497) offers a mechanistically grounded way to study how IMPDH-dependent guanine nucleotide biosynthesis connects immune-cell proliferation, antiviral activity, and host metabolic vulnerability. This thought-leadership guide translates recent PEDV findings into practical experimental and strategic guidance.
-
Pexidartinib: An SPP1-Aware Macrophage Strategy
2026-08-15
Pexidartinib (PLX3397) offers a powerful way to interrogate CSF1R-dependent macrophage biology without confusing cell depletion with phenotypic remodeling. This article connects CSF1R perturbation with SPP1-focused tumor myeloid assays and practical experimental design.
-
Developmental SSRI Exposure Rewires Motivation
2026-08-14
A 2026 Columbia University dissertation shows that developmental SSRI exposure produces persistent, motivation-specific reward deficits in adolescent and adult mice. The work further identifies nucleus accumbens mu opioid receptors as a modifiable component of this phenotype, because pharmacological antagonism and viral knockdown improved effortful behavior whereas later SSRI treatment did not.
-
SIRT1/2 Inhibitor IV: Applied Research Workflows
2026-08-14
SIRT1/2 Inhibitor IV (cambinol) enables mechanistic studies spanning Ran lactylation and astrocyte polarization, p53 acetylation, apoptosis, and tumor growth. This practical guide connects dose-finding, OGD/R assays, cancer-cell validation, and xenograft planning while separating reported evidence from recommended optimization steps.
-
Merimepodib (VX-497): A Metabolic Lens on Antivirals
2026-08-13
Merimepodib (VX-497) turns IMPDH-dependent guanine nucleotide biosynthesis into an experimentally tractable lens for studying viral replication, immune-cell proliferation, and translational metabolism. New PEDV findings strengthen the case for pairing pharmacological inhibition with genetic validation, rescue experiments, and exposure-aware study design.
-
Y-27632: Practical ROCK Inhibitor Workflow
2026-08-13
Y-27632 (SKU B1293) provides a reversible, ATP-competitive way to inhibit ROCK1 and ROCK2 while assessing actin organization and related cytoskeletal responses. It is suited to controlled in vitro and cell-based research, but should not be treated as a therapeutic, diagnostic, or stand-alone proof of pathway specificity in complex biological models.
-
28S rRNA Expansion Segments Build Nucleolar Layers
2026-08-12
Wei et al. show that 28S rRNA expansion segments act as multivalent architectural modules that help establish multilayered nucleolar organization. By combining cellular localization, in vitro reconstitution, comparative analysis, segment deletion, segment transfer, and simulations, the study connects evolutionary RNA expansion with the emergence of complex nucleolar architecture.
-
FH1 for iPS Hepatocyte Maturation Workflows
2026-08-12
FH1 (Catalog No. B3700) supports more functional iPS-derived hepatocyte-like cells by improving albumin secretion, hepatocyte morphology, and CYP3A4-associated maturity while reducing AFP. This guide translates those reported effects into practical culture, assay, troubleshooting, and translational planning steps.
-
HA mRNA Vaccine Protects Dairy Cows Against H5N1
2026-08-11
A hemagglutinin-encoding mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge without detectable effects on health or milk production. The study is notable for showing durable protection in some animals even after serum antibody levels had declined substantially, while also highlighting the need to define immune correlates and RNA chemistry in future work.